Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TRPX

Therapix Biosciences (TRPX) Stock Price, News & Analysis

About Therapix Biosciences Stock (NASDAQ:TRPX)

Advanced Chart

Key Stats

Today's Range
$0.09
$0.12
50-Day Range
$0.10
$0.32
52-Week Range
$0.25
$4.69
Volume
95,212 shs
Average Volume
1.59 million shs
Market Capitalization
$351 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapix Biosciences and its competitors with MarketBeat's FREE daily newsletter.

TRPX Stock News Headlines

Sagimet Biosciences Inc (SGMT)
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
PBIO Pressure BioSciences, Inc.
See More Headlines

TRPX Stock Analysis - Frequently Asked Questions

Therapix Biosciences Ltd. (NASDAQ:TRPX) posted its quarterly earnings results on Monday, August, 20th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.59) by $0.24.

Based on aggregate information from My MarketBeat watchlists, some other companies that Therapix Biosciences investors own include Zynerba Pharmaceuticals (ZYNE), Cara Therapeutics (CARA), Canopy Growth (CGC), Cantel Medical (CMD), Sangamo Therapeutics (SGMO), Corbus Pharmaceuticals (CRBP) and GW Pharmaceuticals (GWPH).

Company Calendar

Last Earnings
8/20/2018
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TRPX
CIK
1611746
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$351 thousand
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:TRPX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners